Pricing
Login
Home
Charts
Search
Watchlist
Products

Albert David Ltd

ALBERTDAVD
₹762.60+0.96%20 Nov 2026
Reports
Pharma Formulations

Albert David Ltd

ALBERTDAVD
₹762.60
+0.96%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹435Cr
Close
Close Price
₹762.60
Industry
Industry
Pharma Formulations
PE
Price To Earnings
15.14
PS
Price To Sales
1.15
Revenue
Revenue
₹378Cr
Rev Gr TTM
Revenue Growth TTM
19.69%
PAT Gr TTM
PAT Growth TTM
290.65%

Quarterly Results

Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
88898998837571879086101101
Growth YoY
Revenue Growth YoY%
18.49.4-2.85.6-5.9-15.9-21.0-11.48.314.743.615.6
Expenses
ExpensesCr
807988928280818579839189
Operating Profit
Operating ProfitCr
810161-5-1131131112
OPM
OPM%
9.510.81.06.30.8-6.3-15.12.912.03.210.511.6
Other Income
Other IncomeCr
17102321-9-522-212-2528-4
Interest Expense
Interest ExpenseCr
000000111010
Depreciation
DepreciationCr
222222222323
PBT
PBTCr
23182225-10-128-320-25365
Tax
TaxCr
5537-1-1115-442
PAT
PATCr
19131918-9-108-315-21323
Growth YoY
PAT Growth YoY%
77.4246.1-19.8-11.0-150.2-180.0-57.9-118.3262.9-107.5303.0187.3
NPM
NPM%
21.214.521.118.4-11.3-13.811.3-3.817.0-25.031.62.9
EPS
EPS₹
32.822.633.031.7-16.4-18.113.9-5.826.8-37.656.15.0
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
88898998837571879086101101
Growth YoY
Revenue Growth YoY%
18.49.4-2.85.6-5.9-15.9-21.0-11.48.314.743.615.6
Expenses
ExpensesCr
807988928280818579839189
Operating Profit
Operating ProfitCr
810161-5-1131131112
OPM
OPM%
9.510.81.06.30.8-6.3-15.12.912.03.210.511.6
Other Income
Other IncomeCr
17102321-9-522-212-2528-4
Interest Expense
Interest ExpenseCr
000000111010
Depreciation
DepreciationCr
222222222323
PBT
PBTCr
23182225-10-128-320-25365
Tax
TaxCr
5537-1-1115-442
PAT
PATCr
19131918-9-108-315-21323
Growth YoY
PAT Growth YoY%
77.4246.1-19.8-11.0-150.2-180.0-57.9-118.3262.9-107.5303.0187.3
NPM
NPM%
21.214.521.118.4-11.3-13.811.3-3.817.0-25.031.62.9
EPS
EPS₹
32.822.633.031.7-16.4-18.113.9-5.826.8-37.656.15.0

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
323295287317321247314342362346334378
Growth
Revenue Growth%
0.3-8.5-2.710.21.2-22.926.78.96.1-4.6-3.519.7
Expenses
ExpensesCr
292267266287290228273297316343328342
Operating Profit
Operating ProfitCr
3128223030194144473536
OPM
OPM%
9.69.47.69.49.47.713.013.012.90.91.69.5
Other Income
Other IncomeCr
4389771716155830712
Interest Expense
Interest ExpenseCr
211111100032
Depreciation
DepreciationCr
98878899771010
PBT
PBTCr
63272229292747519725136
Tax
TaxCr
1510811105121522827
PAT
PATCr
48171318192235367517-129
Growth
PAT Growth%
250.3-64.5-21.031.58.215.559.22.6108.5-77.2-108.7290.6
NPM
NPM%
14.95.84.75.66.08.911.310.620.85.0-0.57.6
EPS
EPS₹
84.128.017.246.733.638.861.863.4132.230.1-2.650.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
323295287317321247314342362346334378
Growth
Revenue Growth%
0.3-8.5-2.710.21.2-22.926.78.96.1-4.6-3.519.7
Expenses
ExpensesCr
292267266287290228273297316343328342
Operating Profit
Operating ProfitCr
3128223030194144473536
OPM
OPM%
9.69.47.69.49.47.713.013.012.90.91.69.5
Other Income
Other IncomeCr
4389771716155830712
Interest Expense
Interest ExpenseCr
211111100032
Depreciation
DepreciationCr
98878899771010
PBT
PBTCr
63272229292747519725136
Tax
TaxCr
1510811105121522827
PAT
PATCr
48171318192235367517-129
Growth
PAT Growth%
250.3-64.5-21.031.58.215.559.22.6108.5-77.2-108.7290.6
NPM
NPM%
14.95.84.75.66.08.911.310.620.85.0-0.57.6
EPS
EPS₹
84.128.017.246.733.638.861.863.4132.230.1-2.650.4
Sales CAGR
1 Year-4%
3 Years-1%
5 Years6%
TTM20%
EBITDA CAGR
1 Year81%
3 Years-50%
5 Years-22%
TTM-
Avg. ROCE
1 Year1%
3 Years11%
5 Years13%
TTM8%
CFO / EBITDA
1 Year-140%
3 Years17%
5 Years43%
TTM-

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
666666666666
Reserves
ReservesCr
131177180205217239274306377387386416
Current Liabilities
Current LiabilitiesCr
7588896881811079999104115117
Non Current Liabilities
Non Current LiabilitiesCr
121314161616141316151214
Total Liabilities
Total LiabilitiesCr
224285290295320341401423498511519554
Current Assets
Current AssetsCr
152164172186201223253304372354374412
Non Current Assets
Non Current AssetsCr
72121118109119118148119126157145142
Total Assets
Total AssetsCr
224285290295320341401423498511519554
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
666666666666
Reserves
ReservesCr
131177180205217239274306377387386416
Current Liabilities
Current LiabilitiesCr
7588896881811079999104115117
Non Current Liabilities
Non Current LiabilitiesCr
121314161616141316151214
Total Liabilities
Total LiabilitiesCr
224285290295320341401423498511519554
Current Assets
Current AssetsCr
152164172186201223253304372354374412
Non Current Assets
Non Current AssetsCr
72121118109119118148119126157145142
Total Assets
Total AssetsCr
224285290295320341401423498511519554

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
682030323037401146-28-8
Investing Cash Flow
Investing Cash FlowCr
-38-37-11-19-20-39-40-5-3323-4
Financing Cash Flow
Financing Cash FlowCr
-187-5-17-10-2-2-6-8012
Net Cash Flow
Net Cash FlowCr
12-1014-40-4-1-14-50
Free Cash Flow
Free Cash FlowCr
6203145153532635-43-37
CFO To PAT
CFO To PAT%
141.8116.4222.6179.8157.8165.3114.629.160.3-165.3512.4
CFO To EBITDA
CFO To EBITDA%
219.171.3138.2107.499.8191.299.123.797.1-939.6-140.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
682030323037401146-28-8
Investing Cash Flow
Investing Cash FlowCr
-38-37-11-19-20-39-40-5-3323-4
Financing Cash Flow
Financing Cash FlowCr
-187-5-17-10-2-2-6-8012
Net Cash Flow
Net Cash FlowCr
12-1014-40-4-1-14-50
Free Cash Flow
Free Cash FlowCr
6203145153532635-43-37
CFO To PAT
CFO To PAT%
141.8116.4222.6179.8157.8165.3114.629.160.3-165.3512.4
CFO To EBITDA
CFO To EBITDA%
219.171.3138.2107.499.8191.299.123.797.1-939.6-140.1

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
171182208225184215304292614463335435
Price To Earnings
Price To Earnings
3.611.421.18.49.69.78.68.18.126.915.1
Price To Sales
Price To Sales
0.50.60.70.70.60.91.00.91.71.31.01.1
Price To Book
Price To Book
1.31.01.11.10.80.91.10.91.61.20.91.0
EV To EBITDA
EV To EBITDA
5.47.19.77.45.99.57.16.112.5156.660.712.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
60.162.560.159.960.659.256.956.158.559.358.758.7
OPM
OPM%
9.69.47.69.49.47.713.013.012.90.91.69.5
NPM
NPM%
14.95.84.75.66.08.911.310.620.85.0-0.57.6
ROCE
ROCE%
41.313.110.514.013.311.416.816.125.36.30.88.3
ROE
ROE%
35.19.37.38.48.69.112.611.619.74.4-0.46.8
ROA
ROA%
21.46.04.76.06.06.58.88.515.13.4-0.35.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
171182208225184215304292614463335435
Price To Earnings
Price To Earnings
3.611.421.18.49.69.78.68.18.126.915.1
Price To Sales
Price To Sales
0.50.60.70.70.60.91.00.91.71.31.01.1
Price To Book
Price To Book
1.31.01.11.10.80.91.10.91.61.20.91.0
EV To EBITDA
EV To EBITDA
5.47.19.77.45.99.57.16.112.5156.660.712.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
60.162.560.159.960.659.256.956.158.559.358.758.7
OPM
OPM%
9.69.47.69.49.47.713.013.012.90.91.69.5
NPM
NPM%
14.95.84.75.66.08.911.310.620.85.0-0.57.6
ROCE
ROCE%
41.313.110.514.013.311.416.816.125.36.30.88.3
ROE
ROE%
35.19.37.38.48.69.112.611.619.74.4-0.46.8
ROA
ROA%
21.46.04.76.06.06.58.88.515.13.4-0.35.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr782660486435402338243
Close PriceClose₹223.81285.00406.05762.60285.9093.41680.10
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE32.1629.2620.8915.1432.1611.11
Price To SalesPS3.283.993.111.151.912.322.13
RevenueRevenueCr239165156378210145114
Revenue Growth TTMRev Gr TTM%13.9%55.2%19.7%27.5%6.1%28.2%
PAT Growth TTMPAT Gr TTM%-13.6%39.5%290.6%41.9%-294.4%26.1%
Market CapitalizationMkt CapCr782660486435402338243
Close PriceClose₹223.81285.00406.05762.60285.9093.41680.10
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE32.1629.2620.8915.1432.1611.11
Price To SalesPS3.283.993.111.151.912.322.13
RevenueRevenueCr239165156378210145114
Revenue Growth TTMRev Gr TTM%13.9%55.2%19.7%27.5%6.1%28.2%
PAT Growth TTMPAT Gr TTM%-13.6%39.5%290.6%41.9%-294.4%26.1%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Load More
Interviews